Synthetix Bio

Premium Testing in Calgary, Alberta
Verification result

Cagrilintide 10mg

Public analytical testing record from Synthetix Bio.

← New search
✓ Certificate verifiedAuthentic report record
Product

Cagrilintide 10mg

Batch CAG-260702-W2COA SB-20261110-00097Peptora Peptide Labs
Sample received2026-11-07
Analysis conducted2026-11-09
Sample typeLyophilized Powder Vial
Report issued2026-11-10
Purity99.5 %
Quantity (actual)10.15 mgLabeled: 10mg
Analytical results

Passed all tests

TestResult
Purity (%)99.5 %
Net content (mg)10.15 mg
IdentityCagrilintide
Endotoxin (EU/mL)0.16 EU/mL
SterilityNo growth
Heavy metals summary (ppm)< 0.1 ppm
Arsenic — As (ppm)0.005 ppm
Cadmium — Cd (ppm).0015 ppm
Lead — Pb (ppm)0.09 ppm
Mercury — Hg (ppm)0.011 ppm
Fentanyl presence analysisNot Present
Batch conformity
VialPurityNet content
V199.7810.15
V299.610.33
V399.510.11
Three-vial comparison

Purity (%)

025507510099.78 %V199.6 %V299.5 %V3

Net content (mg)

02.975.948.9111.8810.15 mgV110.33 mgV210.11 mgV3

Charted from the entered per-vial results. Purity and net content use separate scales. This is a results comparison, not a chromatogram.

Molecular formula

C194H312N54O59S2

CAS number

3387871432

Cap colour / description

White

Laboratory sample ID

SB-301708305

Chromatogram method

RP-HPLC (USP )

Column

C18, 4.6 x 150 mm, 3.5 μm

Detection

UV 214 nm

Retention time

8.06 min

Methods / reporting limits / test conditions

All chemical analyses were performed by HPLC with UV detection coupled with mass spectrometry..

Jonathan KowzkiLaboratory DirectorSynthetix Bio · Calgary, Alberta

Report version 2 · Last saved 2026-11-10 12:07:51. Verification confirms the issued record, separately from analytical outcomes. Findings apply to the submitted sample and stated test conditions. This report does not establish suitability for human use or regulatory approval.

Scroll to Top